Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages

Proteome Science

Volumn 10, Issue 1, 2012, Pages

  Capra, Emanuele ^a,d   Beretta, Riccardo ^a   Parazzi, Valentina ^b   Viganò, Mariele ^b   Lazzari, Lorenza ^b   Baldi, Antonella ^c   Giordano, Rosaria ^b  

^a PARCO TECNOLOGICO PADANO   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Institute Biotrack Srl   (Italy)

Author keywords

AD MSC; Adipose tissue derived mesenchymal stem cells; Calcyclin; Proteomic; S 100A6; SELDI ToF

Indexed keywords

CALCYCLIN;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ARTICLE; CONTROLLED STUDY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEOMICS; STEM CELL EXPANSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

EID: 84869233855     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-10-46     Document Type: Article

References (48)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
2. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000, 109:235-242. 10.1046/j.1365-2141.2000.01986.x, 10848804.
3. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295. 10.1091/mbc.E02-02-0105, 138633, 12475952.
4. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999, 107:275-281. 10.1046/j.1365-2141.1999.01715.x, 10583212.
5. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003, 116:1827-1835. 10.1242/jcs.00369, 12665563.
6. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003, 21:105-110. 10.1634/stemcells.21-1-105, 12529557.
7. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999, 14:1115-1122. 10.1359/jbmr.1999.14.7.1115, 10404011.
8. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008, 45:115-120. 10.1016/j.ymeth.2008.03.006, 18593609.
9. Lin YC, Leu S, Sun CK, Yen CH, Kao YH, Chang LT, Tsai TH, Chua S, Fu M, Ko SF, Wu CJ, Lee FY, Yip HK. Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med 2010, 8:88. 10.1186/1479-5876-8-88, 2956711, 20868517.
10. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006, 24:2582-2591. 10.1634/stemcells.2006-0228, 16873762.
11. Wagner W, Feldmann RE, Seckinger A, Maurer MH, Wein F, Blake J, Krause U, Kalenka A, Bürgers HF, Saffrich R, Wuchter P, Kuschinsky W, Ho AD. The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 2006, 34:536-548. 10.1016/j.exphem.2006.01.002, 16569600.
12. Mareddy S, Broadbent J, Crawford R, Xiao Y. Proteomic profiling of distinct clonal populations of bone marrow mesenchymal stem cells. J Cell Biochem 2009, 106:776-786. 10.1002/jcb.22088, 19229859.
13. Maddox JR, Liao X, Li F, Niyibizi C. Effects of culturing on the stability of the putative murine adipose derived stem cells markers. Open Stem Cell J 2009, 1:54-61. 10.2174/1876893800901010054, 2783658, 19946473.
14. Celebi B, Elçin YM. Proteome analysis of rat bone marrow mesenchymal stem cell subcultures. J Proteome Res 2009, 8:2164-2172. 10.1021/pr800590g, 19323533.
15. Zimmermann S, Biniossek ML, Maurer C, Münzer P, Pantic M, Veelken H, Martens UM. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction. Proteomics 2009, 9:5175-5187. 10.1002/pmic.200900232, 19834903.
16. Siddappa R, Licht R, van Blitterswijk C, de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007, 25:1029-1041. 10.1002/jor.20402, 17469183.
17. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3:e2213. 10.1371/journal.pone.0002213, 2374903, 18493317.
18. Kretlow JD, Jin YQ, Liu W, Zhang WJ, Hong TH, Zhou G, Baggett LS, Mikos AG, Cao Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9:60. 10.1186/1471-2121-9-60, 2584028, 18957087.
19. Karystinou A, Dell'Accio F, Kurth TB, Wackerhage H, Khan IM, Archer CW, Jones EA, Mitsiadis TA, De Bari C. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 2009, 48:1057-1064.
20. Peroni D, Scambi I, Pasini A, Lisi V, Bifari F, Krampera M, Rigotti G, Sbarbati A, Galiè M. Stem molecular signature of adipose-derived stromal cells. Exp Cell Res 2008, 314:603-615. 10.1016/j.yexcr.2007.10.007, 18022619.
21. Secco M, Moreira YB, Zucconi E, Vieira NM, Jazedje T, Muotri AR, Okamoto OK, Verjovski-Almeida S, Zatz M. Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem Cell Rev 2009, 5:387-401. 10.1007/s12015-009-9098-5, 2803263, 20058202.
22. Roche S, Delorme B, Oostendorp RA, Barbet R, Caton D, Noel D, Boumediene K, Papadaki HA, Cousin B, Crozet C, Milhavet O, Casteilla L, Hatzfeld J, Jorgensen C, Charbord P, Lehmann S. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 2009, 9:223-232. 10.1002/pmic.200800035, 19142956.
23. Issaq HJ, Veenstra TD, Conrads TP, Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 2002, 292:587-592. 10.1006/bbrc.2002.6678, 11922607.
24. De Bock M, de Seny D, Meuwis MA, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol 2010, 2010:906082. 2793423, 20029632.
25. Mazzatti DJ, Pawelec G, Longdin R, Powell JR, Forsey RJ. SELDI-TOF-MS ProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin-1 as a potential bio-marker of immunosenescence. Proteome Sci 2007, 5:7. 10.1186/1477-5956-5-7, 1892543, 17550585.
26. McLean K, Wu Y, Gan BS, O'Gorman DB. An alternative kinase activity assay for primary cultures derived from clinical isolates. Clin Invest Med 2009, 32:E84-E94.
27. Reddy G, Dalmasso EA. SELDI ProteinChip® Array Technology: Protein-Based Predictive Medicine and Drug Discovery Applications. J Biomed Biotechnol 2003, 2003:237-241. 10.1155/S1110724303210020, 514271, 14615631.
28. Pilgaard L, Lund P, Duroux M, Lockstone H, Taylor J, Emmersen J, Fink T, Ragoussis J, Zachar V. Transcriptional signature of human adipose tissue-derived stem cells (hASCs) preconditioned for chondrogenesis in hypoxic conditions. Exp Cell Res 2009, 315:1937-1952. 10.1016/j.yexcr.2009.01.020, 19331821.
29. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999, 1450:191-231. 10.1016/S0167-4889(99)00058-0, 10395934.
30. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003, 88:848-854. 10.1002/jcb.10398, 12577318.
31. Okazaki K, Niki I, Iino S, Kobayashi S, Hidaka H. A role of calcyclin, a Ca(2+)-binding protein, on the Ca(2+)-dependent insulin release from the pancreatic beta cell. J Biol Chem 1994, 269:6149-6152.
32. Leśniak W, Słomnicki T, Filipek A. S100A6 - new facts and features. Biochem Biophys Res Commun 2009, 390:1087-1092. 10.1016/j.bbrc.2009.10.150, 19891957.
33. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 2009, 63:410-417. 10.1016/j.lungcan.2008.06.003, 18620780.
34. Nowotny M, Spiechowicz M, Jastrzebska B, Filipek A, Kitagawa K, Kuznicki J. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins. J Biol Chem 2003, 278:26923-26928. 10.1074/jbc.M211518200, 12746458.
35. Kuźnicki J, Kordowska J, Puzianowska M, Woźniewicz BM. Calcyclin as a marker of human epithelial cells and fibroblasts. Exp Cell Res 1992, 200:425-430. 10.1016/0014-4827(92)90191-A, 1572406.
36. Leśniak W, Swart GW, Bloemers HP, Kuźnicki J. Regulation of cell specific expression of calcyclin (S100A6) in nerve cells and other tissues. Acta Neurobiol Exp (Wars) 2000, 60:569-575.
37. Mandinova A, Atar D, Schäfer BW, Spiess M, Aebi U, Heizmann CW. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci 1998, 111:2043-2054.
38. Tsoporis JN, Izhar S, Parker TG. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J Biol Chem 2008, 283:30174-30183. 10.1074/jbc.M805318200, 2662078, 18753141.
39. Lorenz S, Eszlinger M, Paschke R, Aust G, Weick M, Führer D, Krohn K. Calcium signaling of thyrocytes is modulated by TSH through calcium binding protein expression. Biochim Biophys Acta 2010, 1803:352-360. 10.1016/j.bbamcr.2010.01.007, 20083144.
40. Ito M, Kizawa K. Expression of calcium-binding S100 proteins A4 and A6 in regions of the epithelial sac associated with the onset of hair follicle regeneration. J Invest Dermatol 2001, 116:956-963. 10.1046/j.0022-202x.2001.01369.x, 11407987.
41. Silva WA, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669. 10.1634/stemcells.21-6-661, 14595126.
42. Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, Han H, Kim H. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 2005, 23:584-593. 10.1634/stemcells.2004-0304, 15790779.
43. Ghezzo F, Lauret E, Ferrari S, Baserga R. Growth factor regulation of the promoter for calcyclin, a growth-regulated gene. J Biol Chem 1988, 263:4758-4763.
44. Rahimi F, Hsu K, Endoh Y, Geczy CL. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8. FEBS J 2005, 272:2811-2827. 10.1111/j.1742-4658.2005.04703.x, 15943814.
45. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010, 28:788-798. 10.1002/stem.312, 20127798.
46. Marshall J, Krump E, Lindsay T, Downey G, Ford DA, Zhu P, Walker P, Rubin B. Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils. J Immunol 2000, 164:2084-2091.
47. Regonesi ME, Del Favero M, Basilico F, Briani F, Benazzi L, Tortora P, Mauri P, Dehò G. Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach. Biochimie 2006, 88:151-161. 10.1016/j.biochi.2005.07.012, 16139413.
48. Goyak KM, Johnson MC, Strom SC, Omiecinski CJ. Expression profiling of individual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol 2008, 231:216-224. 10.1016/j.taap.2008.04.024, 2610447, 18559280.